Sartorius admitted to TecDAX technology index

Sartorius has announced that it has been admitted to the TecDAX technology index, effective as of June 18th 2012.

German stock exchange organisation Deutsche Borse Group confirmed that Sartorius is to be included in the high-profile index, which lists the 30 largest and most liquid German technology stocks.

The TecDAX ranks just below the blue-chip DAX index and is open only to companies that have adopted a free-float market capitalisation strategy at the time the shares are reviewed.

Dr Joachim Kreuzburg, chief executive officer and executive board chairman of Sartorius, expressed confidence that this move will bring additional attention to the company and its shares.

He added: "I am confident that in the future as well, we will continue to drive our positive business performance that has contributed to our inclusion in this index."

Last month, it was announced that Sartorius Stedim Biotech and c-LEcta have signed a sales and distribution agreement pertaining to the latter company's proprietary Serratia marcescens nuclease products.